Gaithersburg, MD, United States of America

Michael Orr

This inventor holds 1 USPTO granted patent. Top assignee: Ocimum Biosolutions, Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Orr. Retrieved from https://idiyas.com/inventor/michael-orr-9czs4crp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Orr - Innovator in Toxicity Modeling

Introduction

Michael Orr is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of toxicity modeling, particularly through his innovative patent. His work focuses on understanding the global changes in gene expression and identifying toxicity markers in tissues or cells exposed to known toxins.

Latest Patents

Michael Orr holds a patent titled "Primary rat hepatocyte toxicity modeling." This invention elucidates the global changes in gene expression and identifies toxicity markers that can be used in drug screening and toxicity assays. The patent includes a comprehensive database of genes characterized by toxin-induced differential expression, designed for use with microarrays and other solid-phase probes. He has 1 patent to his name.

Career Highlights

Michael Orr is currently employed at Ocimum Biosolutions, Inc., where he continues to advance his research in toxicity modeling. His work has implications for drug development and safety assessments, making him a valuable asset in the field of biomedical research.

Collaborations

Some of his notable coworkers include Donna Mendrick and Mark Porter, who contribute to the collaborative efforts in research and development at Ocimum Biosolutions, Inc.

Conclusion

Michael Orr's innovative work in toxicity modeling and his contributions to the understanding of gene expression in response to toxins highlight his importance in the field. His patent serves as a valuable resource for drug screening and toxicity assays, showcasing his commitment to advancing biomedical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…